BackgroundBowen's disease (BD), also known as squamous intraepidermal carcinoma, is a malignant skin tumor with a potential to progress to invasive carcinoma.ObjectiveWe sought to report a large series of patients with BD treated with Mohs micrographic surgery (MMS).MethodsThis prospective, multicenter, case series included all patients in Australia treated with MMS for BD, who were monitored by the Skin and Cancer Foundation between 1993 and 2002.ResultsThere were 270 cases; the majority (93.4%) were located in the head and neck area. In 50.7% of cases it was a recurrent tumor. In 20% the tumor was initially misdiagnosed as basal cell carcinoma or squamous cell carcinoma. No cases with perineural invasion were diagnosed. There were 6 cases...
ObjectiveTo present the findings of all patients with periocular basal cell carcinoma (BCC) treated ...
Mohs Micrographic Surgery (MMS) is a surgical technique for the removal of cutaneous carcinomas that...
Standard surgery is generally considered the treatment of choice for basal cell carcinomas (BCCs). H...
BACKGROUND: Basosquamous carcinoma (BSC) is a rare tumor defined as a basal cell carcinoma (BCC) dif...
BackgroundOnly a few prospective studies have been published on surgical treatments for cutaneous ba...
BackgroundLong-term follow-up is essential to evaluate the role of Mohs micrographic surgery (MMS) i...
BackgroundOnly a few reports have been published on the long-term outcome of surgical excision of cu...
BackgroundThere are only a small number of reports on the outcome of scalp tumors treated with Mohs ...
BackgroundPerineural invasion (PNI) is an important histologic factor that plays a significant role ...
BackgroundMicrocystic adnexal carcinoma (MAC) is reported to have a high rate of recurrence with sta...
BackgroundPerineural invasion (PNI) is an important factor may possibly influence the aggressiveness...
ObjectiveMohs micrographic surgery (MMS) is the treatment of choice for high-risk primary basal cell...
ObjectiveMohs micrographic surgery (MMS) is the treatment of choice for high-risk primary basal cell...
Bowen's disease is an in situ squamous cell carcinoma of the skin with various treatment modalities ...
BackgroundThe Australian Mohs micrographic surgery (MMS) database was initiated in 1993 by the Skin ...
ObjectiveTo present the findings of all patients with periocular basal cell carcinoma (BCC) treated ...
Mohs Micrographic Surgery (MMS) is a surgical technique for the removal of cutaneous carcinomas that...
Standard surgery is generally considered the treatment of choice for basal cell carcinomas (BCCs). H...
BACKGROUND: Basosquamous carcinoma (BSC) is a rare tumor defined as a basal cell carcinoma (BCC) dif...
BackgroundOnly a few prospective studies have been published on surgical treatments for cutaneous ba...
BackgroundLong-term follow-up is essential to evaluate the role of Mohs micrographic surgery (MMS) i...
BackgroundOnly a few reports have been published on the long-term outcome of surgical excision of cu...
BackgroundThere are only a small number of reports on the outcome of scalp tumors treated with Mohs ...
BackgroundPerineural invasion (PNI) is an important histologic factor that plays a significant role ...
BackgroundMicrocystic adnexal carcinoma (MAC) is reported to have a high rate of recurrence with sta...
BackgroundPerineural invasion (PNI) is an important factor may possibly influence the aggressiveness...
ObjectiveMohs micrographic surgery (MMS) is the treatment of choice for high-risk primary basal cell...
ObjectiveMohs micrographic surgery (MMS) is the treatment of choice for high-risk primary basal cell...
Bowen's disease is an in situ squamous cell carcinoma of the skin with various treatment modalities ...
BackgroundThe Australian Mohs micrographic surgery (MMS) database was initiated in 1993 by the Skin ...
ObjectiveTo present the findings of all patients with periocular basal cell carcinoma (BCC) treated ...
Mohs Micrographic Surgery (MMS) is a surgical technique for the removal of cutaneous carcinomas that...
Standard surgery is generally considered the treatment of choice for basal cell carcinomas (BCCs). H...